Financial statement analysis and common stock valuation
Financial Analyst
Stock Analysis on Net
If you are an investor who values fundamental analysis, you are in the right place. If you need comprehensive financial ratios, read on. You already know that the analysis of financial statements allows you to buy cheap and sell high, now it’s time to put it into practice. Stock Analysis on Net is here for you.
Today, try for free:
Eli Lilly & Co. (NYSE:LLY)
Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Liabilities and stockholders’ equity components shown as percentage of total liabilities and stockholders’ equity.
Enterprise Value to EBITDA (EV/EBITDA)
To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.
Analysis of Solvency Ratios
Quarterly Data
Examines Eli Lilly & Co. capital structure in terms of the mix of its financing sources and the ability of the firm to satisfy its longer-term debt and investment obligations.
Income Statement
Quarterly Data
The income statement (statement of earnings) reports on the performance of Eli Lilly & Co., the result of its operating activities.
Long-term Trends
Enterprise Value to FCFF (EV/FCFF)
Free cash flow to the firm is the cash flow available to the Eli Lilly & Co. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made.
DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data
An approach to decomposing Eli Lilly & Co. return on equity, return on assets, and net profit margin ratio as the product of other financial ratios.
Present Value of Free Cash Flow to Equity (FCFE)
The FCFE valuation approach estimates the value of equity as the present value of future FCFE discounted at the required rate of return on equity.
Analysis of Short-term (Operating) Activity Ratios
Evaluates revenues and output generated by the Eli Lilly & Co. assets. Operating performance ratios describe the relationship between the Eli Lilly & Co. level of operations and the assets needed to sustain operating activities.
Analysis of Solvency Ratios
Examines Eli Lilly & Co. capital structure in terms of the mix of its financing sources and the ability of the firm to satisfy its longer-term debt and investment obligations.
Analysis of Long-term (Investment) Activity Ratios
Quarterly Data
Measures how efficiently Eli Lilly & Co. generates revenues from its investments in fixed or total assets.
Balance Sheet: Assets
The assets reports major classes and amounts of resources owned or controlled by Eli Lilly & Co..
Analysis of Short-term (Operating) Activity Ratios
Quarterly Data
Evaluates revenues and output generated by the Eli Lilly & Co. assets. Operating performance ratios describe the relationship between the Eli Lilly & Co. level of operations and the assets needed to sustain operating activities.
What’s new
Monday, March 2, 2026
UnitedHealth Group Inc. (NYSE:UNH) annual report
for fiscal year ended December 31, 2025
Monday, March 2, 2026
Salesforce Inc. (NYSE:CRM) annual report
for fiscal year ended January 31, 2026
Friday, February 27, 2026
Trade Desk Inc. (NASDAQ:TTD) annual report
for fiscal year ended December 31, 2025
Thursday, February 26, 2026
Thermo Fisher Scientific Inc. (NYSE:TMO) annual report
for fiscal year ended December 31, 2025
Thursday, February 26, 2026
Pfizer Inc. (NYSE:PFE) annual report
for fiscal year ended December 31, 2025
Thursday, February 26, 2026
Eaton Corp. plc (NYSE:ETN) annual report
for fiscal year ended December 31, 2025